Kikuchi N, Nagata K, Horii T, Miyazaki S, Shin M, Takimoto N, Tsuruta Y, Tamaki M, Teraoka H, Yoshida N
Shionogi Research Laboratories, Shionogi & Co., Ltd., Osaka.
J Biochem. 1987 Sep;102(3):607-12. doi: 10.1093/oxfordjournals.jbchem.a122094.
A synthetic gene for human pancreatic secretory trypsin inhibitor (PSTI) was fused to the coding sequence for the amino-terminal 135 amino acid residues of human interferon-gamma (IFN-gamma) by interposing a methionine codon sequence, and the resulting hybrid gene was efficiently expressed in Escherichia coli cells. Recombinant human PSTI (rHu-PSTI) was separated from the IFN-gamma/PSTI fused protein by cleavage at the methionine residue with cyanogen bromide. Finally, rHu-PSTI was purified by affinity chromatography on a bovine trypsin-CH-Sepharose 4B column. The amino acid composition, partial amino-terminal sequence, disulfide formation, human trypsin inhibitory activity, and immunoreactivity against rabbit anti-human PSTI serum of rHu-PSTI corresponded to those of the natural form.
通过插入甲硫氨酸密码子序列,将人胰腺分泌性胰蛋白酶抑制剂(PSTI)的合成基因与人干扰素-γ(IFN-γ)氨基末端135个氨基酸残基的编码序列融合,所得杂交基因在大肠杆菌细胞中高效表达。用溴化氰在甲硫氨酸残基处切割,从IFN-γ/PSTI融合蛋白中分离出重组人PSTI(rHu-PSTI)。最后,通过在牛胰蛋白酶-CH-琼脂糖4B柱上进行亲和层析纯化rHu-PSTI。rHu-PSTI的氨基酸组成、部分氨基末端序列、二硫键形成、人胰蛋白酶抑制活性以及对兔抗人PSTI血清的免疫反应性与天然形式的一致。